Hervé Puy

Gene Therapy in a Patient with Sickle Cell Disease

Jean‐Antoine Ribeil, Salima Hacein‐Bey‐Abina, Emmanuel Payen et al. · New England Journal of Medicine · 2017 · 669 citations · Full text

Medicine, Genetics, Hematology +17

Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia

Alexis A. Thompson, Mark C. Walters, Janet L. Kwiatkowski et al. · New England Journal of Medicine · 2018 · 661 citations · Full text

Medicine, Genetics, Hematology +16

Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion

Nicolas Poté, François Cauchy, Miguel Albuquerque et al. · Journal of Hepatology · 2014 · 334 citations

Medicine, Oncology, Pathology +13

C-Terminal Deletions in the ALAS2 Gene Lead to Gain of Function and Cause X-linked Dominant Protoporphyria without Anemia or Iron Overload

Sharon D. Whatley, Sarah Ducamp, Laurent Gouya et al. · The American Journal of Human Genetics · 2008 · 293 citations · Full text

Life Sciences, Genetics, Molecular Genetics +9

The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH

Laurent Gouya, Hervé Puy, Anne-Marie Robréau et al. · Nature Genetics · 2001 · 264 citations

Life Sciences, Biology, Genetics +2